JSPR
Jasper Therapeutics, Inc.
Company overview
- Market capitalization
- $20.83M
- Employees
- 22
- Latest publication
- 2026-09-29
About Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United States. The company's lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factors from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic spontaneous urticaria, chronic inducible urticaria, and asthma. Jasper Therapeutics, Inc. was founded in 2018 and is headquartered in Redwood City, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 1,174,000USD | 0USD | 0USD |
| Cost Of Revenue | 21,000USD | 290,000USD | — | 258,000USD | 279,000USD | 587,000USD | 541,000USD | 299,000USD |
| Gross Profit | -21,000USD | -290,000USD | — | -258,000USD | -279,000USD | 587,000USD | -541,000USD | -299,000USD |
| Research Development | 5,814,000USD | 11,360,000USD | 14,391,000USD | 21,196,000USD | 16,157,000USD | 19,772,000USD | 14,455,000USD | 11,296,000USD |
| Selling General Administrative | 5,138,000USD | 4,479,000USD | 4,775,000USD | 5,880,000USD | 5,645,000USD | 5,513,000USD | 5,434,000USD | 4,697,000USD |
| Total Operating Expenses | 10,931,000USD | 15,839,000USD | 19,166,000USD | 27,076,000USD | 21,802,000USD | 25,285,000USD | 19,889,000USD | 15,993,000USD |
| Operating Income | -10,952,000USD | -15,839,000USD | -19,166,000USD | -27,076,000USD | -21,802,000USD | -25,285,000USD | -19,889,000USD | -15,993,000USD |
| Interest Income | 164,000USD | 338,000USD | 342,000USD | 437,000USD | 624,000USD | 938,000USD | 1,284,000USD | 1,450,000USD |
| Net Interest Income | 164,000USD | 338,000USD | 342,000USD | 437,000USD | 624,000USD | 938,000USD | 1,284,000USD | 1,450,000USD |
| Income Before Tax | -1,174,000USD | -9,101,000USD | -18,736,000USD | -26,723,000USD | -21,241,000USD | -24,321,000USD | -18,637,000USD | -14,583,000USD |
| Net Income | -1,174,000USD | -9,101,000USD | -18,736,000USD | -26,723,000USD | -21,241,000USD | -24,321,000USD | -18,637,000USD | -14,583,000USD |
| Net Income From Continuing Ops | -1,174,000USD | -9,101,000USD | -18,736,000USD | -26,723,000USD | -21,241,000USD | -24,321,000USD | -18,637,000USD | -14,583,000USD |
| Ebit | -10,973,000USD | -15,839,000USD | -18,736,000USD | -27,076,000USD | -21,802,000USD | -25,285,000USD | -19,889,000USD | -15,993,000USD |
| Ebitda | -10,952,000USD | -15,549,000USD | -18,507,000USD | -26,818,000USD | -21,523,000USD | -25,040,000USD | -19,348,000USD | -15,694,000USD |
| Depreciation And Amortization | 21,000USD | 290,000USD | 229,000USD | 258,000USD | 279,000USD | 245,000USD | 541,000USD | 299,000USD |
| Reconciled Depreciation | 21,000USD | 290,000USD | 229,000USD | 258,000USD | 279,000USD | 245,000USD | 541,000USD | 299,000USD |
| Total Other Income Expense Net | 9,778,000USD | 6,738,000USD | 430,000USD | 353,000USD | 561,000USD | 964,000USD | 1,252,000USD | 1,410,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | 288,000USD | — | — |
| Interest Expense | — | — | — | — | — | 5,058,000USD | — | — |
| Income Tax Expense | — | — | — | — | — | 54,276USD | — | -299,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 13,511,000USD | 6,196,000USD | 0USD | — |
| Cost Of Revenue | 1,056,000USD | 1,373,000USD | 1,108,000USD | 1,310,000USD | 566,000USD | 21,000USD | — |
| Gross Profit | -1,056,000USD | -1,373,000USD | -1,108,000USD | -1,310,000USD | -566,000USD | -21,000USD | — |
| Research Development | 60,518,000USD | 55,821,000USD | 51,785,000USD | 34,627,000USD | 25,421,000USD | 15,883,000USD | 3,618,000USD |
| Selling General Administrative | 18,944,000USD | 20,418,000USD | 17,076,000USD | 16,569,000USD | 11,412,000USD | 4,800,000USD | 1,092,000USD |
| Total Operating Expenses | 79,462,000USD | 76,239,000USD | 68,861,000USD | 51,196,000USD | 36,833,000USD | 20,683,000USD | 4,710,000USD |
| Operating Income | -80,518,000USD | -76,239,000USD | -68,861,000USD | -51,196,000USD | -36,833,000USD | -20,683,000USD | -4,710,000USD |
| Interest Income | 1,741,000USD | 5,058,000USD | 5,199,000USD | 701,000USD | — | — | — |
| Net Interest Income | 1,741,000USD | 5,058,000USD | 5,199,000USD | 701,000USD | — | — | — |
| Income Before Tax | -75,801,000USD | -71,269,000USD | -64,465,000USD | -37,685,000USD | -30,637,000USD | -31,669,000USD | -4,987,000USD |
| Net Income | -75,801,000USD | -71,269,000USD | -64,465,000USD | -37,685,000USD | -30,637,000USD | -31,669,000USD | -4,987,000USD |
| Net Income From Continuing Ops | -75,801,000USD | -71,269,000USD | -64,465,000USD | -51,196,000USD | -36,833,000USD | -6,480,701USD | — |
| Ebit | -80,518,000USD | -76,239,000USD | -68,861,000USD | -51,196,000USD | -36,833,000USD | -31,967,000USD | -4,987,000USD |
| Ebitda | -79,462,000USD | -74,866,000USD | -67,753,000USD | -50,221,000USD | -36,456,000USD | -31,946,000USD | -277,000USD |
| Depreciation And Amortization | 1,056,000USD | 1,373,000USD | 1,108,000USD | 975,000USD | 377,000USD | 20,683,000USD | 4,710,000USD |
| Reconciled Depreciation | 1,056,000USD | 1,373,000USD | 1,108,000USD | 975,000USD | 377,000USD | 0USD | — |
| Total Other Income Expense Net | 4,717,000USD | 4,970,000USD | 4,396,000USD | 13,511,000USD | 6,196,000USD | -10,986,000USD | -277,000USD |
| Income Tax Expense | — | -1,492,000USD | -1,628,000USD | -13,511,000USD | -1,095,000USD | -38,451USD | -277USD |
| Interest Expense | — | — | — | 13,511,000USD | 6,196,000USD | 10,986,000USD | 0USD |
| Net Income Applicable To Common Shares | — | — | — | -37,685,000USD | -30,637,000USD | -6,480,701USD | -4,987,000USD |
| Non Operating Income Net Other | — | — | — | — | — | -5,506,850USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 11,802,000USD | 21,184,000USD | 35,779,000USD | 57,469,000USD | 46,466,000USD | 57,597,000USD | 79,899,000USD | 99,413,000USD |
| Cash And Equivalents | 7,314,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 270,814,000USD | 14,144,000USD | 28,692,000USD | 50,899,000USD | 39,510,000USD | 48,799,000USD | 71,637,000USD | 92,502,000USD |
| Short Term Investments | 263,500,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 11,571,000USD | 20,292,000USD | 34,645,000USD | 54,564,000USD | 42,966,000USD | 53,174,000USD | 75,811,000USD | 94,806,000USD |
| Other Current Assets | 255,000USD | 6,148,000USD | 5,953,000USD | 3,665,000USD | 3,456,000USD | 4,375,000USD | 4,174,000USD | 2,054,000USD |
| Other Non Current Assets | 43,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 10,389,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 7,845,000USD | 8,996,000USD | 13,200,000USD | 21,041,000USD | 20,500,000USD | 12,334,000USD | 15,237,000USD | 12,459,000USD |
| Total Stockholder Equity | 1,413,000USD | 3,400,000USD | 4,151,000USD | 11,571,000USD | 23,501,000USD | 42,244,000USD | 61,674,000USD | 83,680,000USD |
| Total Equity Including Noncontrolling Interest | 1,413,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 188,000USD | 398,000USD | 604,000USD | 2,338,000USD | 2,891,000USD | 3,474,000USD | 2,851,000USD | 3,177,000USD |
| Accounts Payable | 2,778,000USD | 2,439,000USD | 6,220,000USD | 9,166,000USD | 8,034,000USD | 2,995,000USD | 4,027,000USD | 3,086,000USD |
| Short Term Debt | 270,000USD | 757,000USD | 1,235,000USD | 1,703,000USD | 1,954,000USD | 1,835,000USD | 1,089,000USD | 1,059,000USD |
| Common Stock | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD |
| Retained Earnings | -320,604,000USD | -317,844,000USD | -316,670,000USD | -307,569,000USD | -288,833,000USD | -262,110,000USD | -240,869,000USD | -216,548,000USD |
| Total Liab | — | 17,784,000USD | 31,628,000USD | 45,898,000USD | 22,965,000USD | 15,353,000USD | 18,225,000USD | 15,733,000USD |
| Other Current Liab | — | 5,800,000USD | 5,745,000USD | 10,172,000USD | 10,512,000USD | 7,504,000USD | 10,121,000USD | 8,314,000USD |
| Capital Stock | — | 3,000USD | 3,000USD | 3,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD |
| Cash | — | 14,144,000USD | 28,692,000USD | 50,899,000USD | 39,510,000USD | 48,799,000USD | 71,637,000USD | 92,502,000USD |
| Net Debt | — | -13,387,000USD | -27,457,000USD | -49,196,000USD | -37,355,000USD | -46,209,000USD | -69,824,000USD | -90,433,000USD |
| Short Long Term Debt Total | — | 757,000USD | 1,235,000USD | 1,703,000USD | 2,155,000USD | 2,590,000USD | 1,813,000USD | 2,069,000USD |
| Property Plant Equipment Gross | — | 5,233,000USD | 5,418,000USD | 6,243,000USD | 6,707,000USD | 7,552,000USD | 6,658,000USD | 6,765,000USD |
| Common Stock Shares Outstanding | — | 15,333,962shares | 15,333,962shares | 16,635,784shares | 15,333,962shares | 15,022,122shares | 15,008,473shares | 15,000,516shares |
| Non Current Assets Total | — | 892,000USD | 1,134,000USD | 2,905,000USD | 3,500,000USD | 4,423,000USD | 4,088,000USD | 4,607,000USD |
| Non Current Liabilities Total | — | 8,788,000USD | 18,428,000USD | 24,857,000USD | 2,465,000USD | 3,019,000USD | 2,988,000USD | 3,274,000USD |
| Non Current Liabilities Other | — | 2,264,000USD | 2,264,000USD | 2,264,000USD | 2,264,000USD | 2,264,000USD | 2,264,000USD | 2,264,000USD |
| Non Currrent Assets Other | — | 494,000USD | 530,000USD | 150,000USD | 609,000USD | 532,000USD | 820,000USD | 1,013,000USD |
| Net Working Capital | — | 11,296,000USD | 21,445,000USD | 33,523,000USD | 22,466,000USD | 40,840,000USD | 60,574,000USD | 82,347,000USD |
| Unclassified Non Current Liabilities | — | 6,524,000USD | 16,164,000USD | 22,593,000USD | — | — | — | 1,010,000USD |
| Unclassified Equity | — | 321,238,000USD | 320,815,000USD | 319,134,000USD | 312,330,000USD | 304,350,000USD | 302,539,000USD | 300,224,000USD |
| Accumulated Other Comprehensive Income | — | — | — | — | 0USD | — | — | — |
| Net Receivables | — | — | — | — | — | — | — | 250,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 35,779,000USD | 79,899,000USD | 94,892,000USD | 48,361,000USD | 93,654,000USD | 23,357,000USD | 27,211,000USD |
| Other Current Assets | 5,953,000USD | 4,174,000USD | 1,801,000USD | 3,481,000USD | 3,130,000USD | 247,000USD | -72,991,572USD |
| Total Liab | 31,628,000USD | 18,225,000USD | 16,452,000USD | 12,372,000USD | 24,136,000USD | 58,487,000USD | 6,109,000USD |
| Total Stockholder Equity | 4,151,000USD | 61,674,000USD | 78,440,000USD | 35,989,000USD | 69,518,000USD | -35,130,000USD | 21,102,000USD |
| Other Current Liab | 5,745,000USD | 10,121,000USD | 7,253,000USD | 4,432,000USD | 3,596,000USD | 2,595,000USD | 1,370,000USD |
| Common Stock | 3,000USD | 2,000USD | 1,000USD | 4,000USD | 4,000USD | 1,000USD | 10,000USD |
| Capital Stock | 3,000USD | 2,000USD | 1,000USD | 4,000USD | 4,000USD | 1,000USD | — |
| Retained Earnings | -316,670,000USD | -240,869,000USD | -169,600,000USD | -105,135,000USD | -67,450,000USD | -36,813,000USD | -5,144,000USD |
| Cash | 28,692,000USD | 71,637,000USD | 86,887,000USD | 38,250,000USD | 84,701,000USD | 19,838,000USD | 27,163,000USD |
| Cash And Short Term Investments | 28,692,000USD | 71,637,000USD | 86,887,000USD | 38,250,000USD | 84,701,000USD | 19,838,000USD | 27,163,000USD |
| Total Current Assets | 34,645,000USD | 75,811,000USD | 88,938,000USD | 41,731,000USD | 87,831,000USD | 20,685,000USD | 27,163,000USD |
| Total Current Liabilities | 13,200,000USD | 15,237,000USD | 12,374,000USD | 7,065,000USD | 8,020,000USD | 4,012,000USD | 1,993,000USD |
| Net Debt | -27,457,000USD | -69,824,000USD | -84,101,000USD | -34,599,000USD | -81,816,000USD | -18,214,000USD | -27,163,000USD |
| Short Term Debt | 1,235,000USD | 1,089,000USD | 972,000USD | 865,000USD | 505,000USD | — | — |
| Short Long Term Debt Total | 1,235,000USD | 1,813,000USD | 2,786,000USD | 3,651,000USD | 2,885,000USD | 1,624,000USD | — |
| Accounts Payable | 6,220,000USD | 4,027,000USD | 4,149,000USD | 1,768,000USD | 3,919,000USD | 1,417,000USD | 623,000USD |
| Property Plant Equipment Net | 604,000USD | 2,851,000USD | 4,194,000USD | 5,454,000USD | 4,833,000USD | 2,029,000USD | — |
| Property Plant Equipment Gross | 5,418,000USD | 6,658,000USD | 6,654,000USD | 5,454,000USD | 4,833,000USD | 2,029,000USD | — |
| Common Stock Shares Outstanding | 15,333,962shares | 14,584,870shares | 10,439,034shares | 3,648,140shares | 1,139,375shares | 172,982shares | 176,000shares |
| Non Current Assets Total | 1,134,000USD | 4,088,000USD | 5,954,000USD | 6,630,000USD | 5,823,000USD | 2,672,000USD | 48,000USD |
| Non Current Liabilities Total | 18,428,000USD | 2,988,000USD | 4,078,000USD | 5,307,000USD | 16,116,000USD | 54,475,000USD | 4,116,000USD |
| Non Current Liabilities Other | 2,264,000USD | 2,264,000USD | 2,264,000USD | 5,307,000USD | 16,116,000USD | 3,500,000USD | 3,500,000USD |
| Non Currrent Assets Other | 530,000USD | 820,000USD | 1,343,000USD | 1,176,000USD | 990,000USD | 643,000USD | 48,000USD |
| Net Working Capital | 21,445,000USD | 60,574,000USD | 76,564,000USD | 34,666,000USD | 79,811,000USD | 16,673,000USD | — |
| Unclassified Non Current Liabilities | 16,164,000USD | — | 1,814,000USD | -2,521,000USD | -13,736,000USD | 28,834,000USD | -3,500,000USD |
| Unclassified Equity | 320,815,000USD | 302,539,000USD | 248,038,000USD | 141,116,000USD | 230,614,000USD | 45,521,000USD | 26,236,000USD |
| Other Assets | — | — | 1USD | 0USD | 990,000USD | 643,000USD | 48,000USD |
| Net Receivables | — | — | 250,000USD | 1,159,000USD | 698,000USD | 600,000USD | — |
| Other Liab | — | — | — | 2,521,000USD | 13,736,000USD | 9,011,000USD | 4,116,000USD |
| Accumulated Other Comprehensive Income | — | — | — | 0USD | -93,654,000USD | -43,840,000USD | — |
| Net Tangible Assets | — | — | — | 35,989,000USD | 69,518,000USD | 84,361,570USD | 98,082,271USD |
| Unclassified Current Assets | — | — | — | -1,159,000USD | — | — | -100,154,572USD |
| Current Deferred Revenue | — | — | — | — | 2,811,000USD | — | — |
| Inventory | — | — | — | — | -548,000USD | 95,472USD | — |
| Unclassified Current Liabilities | — | — | — | — | -2,811,000USD | — | — |
| Long Term Debt | — | — | — | — | — | 13,130,000USD | — |
| Long Term Investments | — | — | — | — | — | 100,339,379USD | 100,154,572USD |
| Unclassified Non Current Assets | — | — | — | — | — | -100,982,379USD | -100,202,572USD |
| Short Term Investments | — | — | — | — | — | — | 100,154,572USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 42,000USD |
| Stock Based Compensation | 1,187,000USD |
| Change To Liabilities | -4,390,000USD |
| Change In Working Capital | -1,259,000USD |
| Operating Cash Flow | -21,467,000USD |
| Investing Cash Flow | 80,000USD |
| Common Stock Issuance | 9,000USD |
| Financing Cash Flow | 9,000USD |
| Change In Cash | -21,378,000USD |
| End Cash Flow | 7,731,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -1,174,000USD | -9,101,000USD | -18,736,000USD | -26,723,000USD | -21,241,000USD | -24,321,000USD | -18,637,000USD | -14,583,000USD |
| Depreciation | 21,000USD | 290,000USD | 229,000USD | 258,000USD | 279,000USD | 245,000USD | 541,000USD | 299,000USD |
| Stock Based Compensation | 423,000USD | 1,661,000USD | 1,424,000USD | 1,817,000USD | 1,811,000USD | 1,970,000USD | 1,998,000USD | 1,482,000USD |
| Other Non Cash Items | -9,032,000USD | -4,987,000USD | 271,000USD | 317,000USD | 193,000USD | 141,000USD | 2,103,000USD | 120,000USD |
| Change In Working Capital | -4,363,000USD | -9,730,000USD | -187,000USD | 8,878,000USD | -3,884,000USD | 831,000USD | 1,941,000USD | 1,002,000USD |
| Total Cash From Operating Activities | -14,548,000USD | -21,867,000USD | -16,999,000USD | -15,453,000USD | -22,842,000USD | -21,134,000USD | -14,052,000USD | -11,680,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | -7,000USD | 0USD | -96,000USD | -274,000USD | -157,000USD |
| Free Cash Flow | -14,548,000USD | -21,867,000USD | -16,999,000USD | -15,460,000USD | -22,842,000USD | -21,230,000USD | -14,326,000USD | -11,837,000USD |
| Change In Cash | -14,548,000USD | -22,207,000USD | 11,389,000USD | -9,289,000USD | -22,838,000USD | -20,865,000USD | -14,317,000USD | -11,656,000USD |
| Begin Period Cash Flow | 28,692,000USD | 51,316,000USD | 39,927,000USD | 49,216,000USD | 72,054,000USD | 92,502,000USD | 106,819,000USD | 118,475,000USD |
| End Period Cash Flow | 14,144,000USD | 29,109,000USD | 51,316,000USD | 39,927,000USD | 49,216,000USD | 71,637,000USD | 92,502,000USD | 106,819,000USD |
| Total Cashflows From Investing Activities | — | 76,000USD | 76,000USD | 1,000USD | 4,000USD | -76,000USD | -274,000USD | -157,000USD |
| Total Cash From Financing Activities | — | -340,000USD | 28,388,000USD | 6,163,000USD | 0USD | 345,000USD | 9,000USD | 181,000USD |
| Sale Purchase Of Stock | — | -203,000USD | — | 223,000USD | — | 315,000USD | 45,000USD | — |
| Issuance Of Capital Stock | — | 27,514,000USD | 514,000USD | 5,940,000USD | 0USD | 0USD | 0USD | 0USD |
| Other Cashflows From Investing Activities | — | 76,000USD | 76,000USD | 8,000USD | 4,000USD | 20,000USD | 182,000USD | — |
| Other Cashflows From Financing Activities | — | -340,000USD | 27,874,000USD | 223,000USD | — | 47,540,000USD | 9,000USD | 181,000USD |
| Investments | — | — | 0USD | 1,000USD | 4,000USD | -76,000USD | -274,000USD | -157,000USD |
| Unclassified Financing Cash Flow | — | — | — | 5,717,000USD | — | -47,510,000USD | — | — |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | -1,998,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | -75,801,000USD | -71,269,000USD | -64,465,000USD | -37,685,000USD | -30,637,000USD | -31,669,000USD | -4,987,000USD |
| Depreciation | 1,056,000USD | 1,373,000USD | 1,108,000USD | 1,310,000USD | 377,000USD | 21,000USD | 377,000USD |
| Stock Based Compensation | 6,713,000USD | 6,619,000USD | 5,211,000USD | 4,091,000USD | 1,048,000USD | 1,210,000USD | 6,000USD |
| Other Non Cash Items | -4,206,000USD | 502,000USD | 976,000USD | -8,834,000USD | -6,087,000USD | 10,896,000USD | 1,620,000USD |
| Change In Working Capital | -4,923,000USD | 173,000USD | 5,103,000USD | -649,000USD | 1,621,000USD | 1,296,000USD | 1,392,000USD |
| Total Cash From Operating Activities | -77,161,000USD | -62,602,000USD | -52,067,000USD | -45,858,000USD | -33,678,000USD | -18,267,000USD | -1,969,000USD |
| Capital Expenditures | -7,000USD | -552,000USD | -267,000USD | -576,000USD | -2,428,000USD | -2,428,000USD | -2,428,000USD |
| Free Cash Flow | -77,168,000USD | -63,154,000USD | -52,334,000USD | -46,434,000USD | -36,106,000USD | -18,267,000USD | -1,969,000USD |
| Total Cashflows From Investing Activities | 5,000USD | -532,000USD | -267,000USD | -576,000USD | -2,428,000USD | 198,343USD | -2,428,000USD |
| Total Cash From Financing Activities | 34,211,000USD | 47,884,000USD | 100,971,000USD | 55,000USD | 100,969,000USD | 11,287,000USD | 29,128,000USD |
| Sale Purchase Of Stock | 243,000USD | 360,000USD | -960,000USD | 28,000USD | 5,698,000USD | — | — |
| Issuance Of Capital Stock | 33,968,000USD | 47,195,000USD | 101,479,000USD | 101,479,000USD | 10,750,000USD | 11,234,000USD | — |
| Change In Cash | -42,945,000USD | -15,250,000USD | 48,637,000USD | -46,451,000USD | 64,863,000USD | -6,980,000USD | 27,162,996USD |
| Begin Period Cash Flow | 72,054,000USD | 87,304,000USD | 38,667,000USD | 84,701,000USD | 20,183,000USD | 27,163,000USD | 4USD |
| End Period Cash Flow | 29,109,000USD | 72,054,000USD | 87,304,000USD | 38,250,000USD | 85,046,000USD | 20,183,000USD | 27,163,000USD |
| Other Cashflows From Investing Activities | 12,000USD | 20,000USD | — | — | — | 198,343USD | — |
| Other Cashflows From Financing Activities | 34,211,000USD | 689,000USD | -508,000USD | 55,000USD | 100,969,000USD | 11,287,000USD | 27,628,000USD |
| Investments | — | -532,000USD | -267,000USD | -576,000USD | -2,428,000USD | 0USD | — |
| Unclassified Financing Cash Flow | — | 46,835,000USD | 102,439,000USD | — | -5,698,000USD | -11,234,000USD | — |
| Change To Account Receivables | — | — | 663,000USD | -663,000USD | 600,000USD | 600,000USD | 600,000USD |
| Change To Inventory | — | — | — | 663,000USD | -600,000USD | — | — |
| Change To Liabilities | — | — | — | 405,000USD | 3,697,000USD | 158,087USD | 536,000USD |
| Net Borrowings | — | — | — | 72,000USD | — | — | 1,500,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -46,379,000USD | 64,863,000USD | -442,641USD | — |
| Unclassified Operating Cash Flow | — | — | — | -4,091,000USD | — | — | — |
| Unclassified Investing Cash Flow | — | — | — | — | 2,428,000USD | 2,428,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.